You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
華仁藥業(300110.SZ):2019年淨利預增0-20%
格隆匯 01-17 19:56

格隆匯1月17日丨華仁藥業(300110.SZ)披露2019年年度業績預告,公司預計2019年1-12月歸屬於上市公司股東的淨利潤為3879.48-4655.38萬元,同比增長0-20%。業績變動原因如下:

1、報告期內,公司控股權發生變更,控股股東變更為西安曲江天授大健康投資合夥企業(有限合夥),實際控制人變更為西安曲江新區管理委員會。為適應經營發展的需求,公司調整組織架構,通過組織變革推動公司成長,各項業務穩步推進。市場開拓方面,公司依託現有產品線,整合內部資源,加大市場融合開發力度,提高產品覆蓋的深度與廣度,整體盈利情況較去年同期保持一定增長。

2、預計2019年度非經常性歸屬母公司損益為-320萬元左右,具體以2019年年度報告披露的財務數據為準。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account